Skip to main content

Table 2 Comparison of baseline and end-of-follow-up parameters in patients with central retinal vein occlusion

From: Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

  Dexamethasone (n = 20) Triamcinolone (n = 20)
Baseline After P Baseline After P
BCVA (log MAR ± SD) 1.06 ± 0.13 0.637 ± 0.54 0.0179 0.99 ± 0.15 0.508 ± 0.45 0.0142
CMT (µm) 551 ± 17.16 237 ± 20.71 0.0050 547.5 ± 13.79 232.6 ± 18.54 0.0050
IOP (mmHg) 16.7 ± 1.16 17 ± 1.94 0.7083 16.1 ± 2.60 22.2 ± 4.93 0.0076
  1. BCVA best-corrected visual acuity, CMT central macular thickness, IOP intraocular pressure, NS not significant